SC 13D/A

NEW ENTERPRISE ASSOCIATES 16, L.P. -- SCHEDULE 13DA1

Company: Trevi Therapeutics, Inc.
Filed: April 16, 2020
Accession Number: 0001072613-20-000163

View Document ↗ View on SEC.gov ↗